Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zane S Kaplan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Blood|September 18, 2010
SR-BI and fatty plateletsZane S Kaplan, Shaun P Jackson
Hematology. American Society of Hematology. Education Program|December 14, 2011
The role of platelets in atherothrombosisZane S Kaplan, Shaun P Jackson
Blood|December 21, 2012
Parvovirus B19–induced pure red cell aplasia in a heart transplant recipientChun Yew Fong, Zane S Kaplan
Transfusion Medicine Reviews|February 15, 2015
Platelets are not just for clotsJames D McFadyen, Zane S Kaplan
British Journal of Haematology|July 20, 2016
Factor VIII inhibitor eradication with bortezomib in acquired haemophilia AJames D McFadyen, Huyen Tran, Zane S Kaplan
Nature Communications|July 24, 2015
Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4Zane S Kaplan, Alessandro Zarpellon, Imala Alwis, et al.
Blood|February 23, 2013
Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263)Jianlin Qiao, Simone M Schoenwaelder, Kylie D Mason, et al.
Blood Advances|January 4, 2018
Bortezomib-based antibody depletion for refractory autoimmune hematological diseasesSumita Ratnasingam, Patricia A Walker, Huy Tran, et al.
Blood|April 4, 2013
The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombiMehran Ghasemzadeh, Zane S Kaplan, Imala Alwis, et al.
The Lancet. Haematology|July 14, 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionFrédéric B Piel, David C Rees, Michael R DeBaun, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood|September 18, 2010
SR-BI and fatty plateletsZane S Kaplan, Shaun P Jackson
Hematology. American Society of Hematology. Education Program|December 14, 2011
The role of platelets in atherothrombosisZane S Kaplan, Shaun P Jackson
Blood|December 21, 2012
Parvovirus B19–induced pure red cell aplasia in a heart transplant recipientChun Yew Fong, Zane S Kaplan
Transfusion Medicine Reviews|February 15, 2015
Platelets are not just for clotsJames D McFadyen, Zane S Kaplan
British Journal of Haematology|July 20, 2016
Factor VIII inhibitor eradication with bortezomib in acquired haemophilia AJames D McFadyen, Huyen Tran, Zane S Kaplan
Nature Communications|July 24, 2015
Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4Zane S Kaplan, Alessandro Zarpellon, Imala Alwis, et al.
Blood|February 23, 2013
Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263)Jianlin Qiao, Simone M Schoenwaelder, Kylie D Mason, et al.
Blood Advances|January 4, 2018
Bortezomib-based antibody depletion for refractory autoimmune hematological diseasesSumita Ratnasingam, Patricia A Walker, Huy Tran, et al.
Blood|April 4, 2013
The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombiMehran Ghasemzadeh, Zane S Kaplan, Imala Alwis, et al.
The Lancet. Haematology|July 14, 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionFrédéric B Piel, David C Rees, Michael R DeBaun, et al.
Pageof 1